JNJ-87189401 not checked
Johnson & Johnson (Janssen) · PSMAxCD28
FollowEvery change as it happens, and a Monday email
Trials
3 active
3 in total · 2 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Prostatic Neoplasms (2 trials), Metastatic Castration-resistant Prostatic Neoplasms
- Main trialPhase 3
- “The purpose of this study is to evaluate the overall survival (length of time from the start of study to date of death from any cause) for pasritamig (JNJ-78278343) in Part 1 in combination with best supportive care (BSC) and in Part 2 with JNJ-87189401+BSC as compared to placebo with BSC in participants with metastatic castration-resistant prostate cancer (mCRPC; a stage of cancer that has spread beyond the prostate gland and is no longer responding to hormone therapies).”In the company’s words, NCT07164443 on ClinicalTrials.gov
- Other names
- PSMAxCD28
Other drugs for Prostatic Neoplasms
- ApalutamideJohnson & Johnson (Janssen) · Phase 3
- 64Cu-SAR-bisPSMAClarity Pharmaceuticals Ltd · Phase 3
- Abiraterone acetateJohnson & Johnson (Janssen) · Phase 3
- 68Ga-PSMA-11Telix Pharmaceuticals (Innovations) Pty Limited · Phase 3
- EnzalutamidePfizer · Astellas · Phase 3
- MevrometostatPfizer · Phase 3
Coming up3
- 21 Jun 2027Phase 1 trial completes · ClinicalTrials.gov
- 30 Nov 2027Phase 1 trial completes · ClinicalTrials.gov
- 18 Aug 2028Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials3
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 18 Aug 2028 | A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) | |
| Phase 1Recruiting | 21 Jun 2027 | A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer | |
| Phase 1Recruiting | 30 Nov 2027 | A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026